A comprehensive study of 194 Chinese patients with myasthenia gravis in Hong Kong has shown distinct differences from the patterns of disease seen in Caucasians. Restricted ocular myasthenia is the predominant disease type in patients presenting in the first two decades of life and is associated with absence or low titres of acetylcholine receptor antibody. Predisposition to this type of disease is strongly associated with HLA-DRw9. Generalized myasthenia gravis occurs predominantly in patients presenting after the age of 20 years and is accompanied by high titres of acetylcholine receptor antibody but is less strongly associated with HLA-DRw9. It is suggested that myasthenia gravis occurring within the first two decades of life and charact...
Familial Autoimmune Myasthenia Gravis (FAMG) is rarely reported. We present a mother and son with la...
Background. Previous reports describe ethnicity based differences in clinical and laboratory feature...
Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4), a critical negative regulator of th...
Thirty seven Chinese adults and 23 children in Hong Kong with myasthenia gravis were tested for HLA-...
BACKGROUND: Ocular and childhood myasthenia gravis (MG) cases seem relatively more common in Orienta...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diag-nosed...
Acquired myasthenia gravis (MG) is a prototype autoimmune disease of the neuromuscular junction, cau...
Myasthenia gravis (MG) is an acquired autoimmune disease affecting synaptic transmission via the neu...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diagnosed ...
AbstractCirculating antibodies of the acetylcholine receptor (AchRAb) are detectable in most patient...
A territory-wide study of myasthenia gravis (MG) was conducted in Hong Kong. Two hundred and sixty-t...
This study aims to investigate genetic susceptibility to early-onset and late-onset anti-acetylcholi...
Several reports from Western countries suggest differences in the clinical features of patients with...
In a study covering 85% of the population of Hong Kong, 39% of all myasthenia gravis (MG) patients, ...
to myasthenia gravis (MG), but the contribution in East Asians has not been established. variants i...
Familial Autoimmune Myasthenia Gravis (FAMG) is rarely reported. We present a mother and son with la...
Background. Previous reports describe ethnicity based differences in clinical and laboratory feature...
Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4), a critical negative regulator of th...
Thirty seven Chinese adults and 23 children in Hong Kong with myasthenia gravis were tested for HLA-...
BACKGROUND: Ocular and childhood myasthenia gravis (MG) cases seem relatively more common in Orienta...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diag-nosed...
Acquired myasthenia gravis (MG) is a prototype autoimmune disease of the neuromuscular junction, cau...
Myasthenia gravis (MG) is an acquired autoimmune disease affecting synaptic transmission via the neu...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diagnosed ...
AbstractCirculating antibodies of the acetylcholine receptor (AchRAb) are detectable in most patient...
A territory-wide study of myasthenia gravis (MG) was conducted in Hong Kong. Two hundred and sixty-t...
This study aims to investigate genetic susceptibility to early-onset and late-onset anti-acetylcholi...
Several reports from Western countries suggest differences in the clinical features of patients with...
In a study covering 85% of the population of Hong Kong, 39% of all myasthenia gravis (MG) patients, ...
to myasthenia gravis (MG), but the contribution in East Asians has not been established. variants i...
Familial Autoimmune Myasthenia Gravis (FAMG) is rarely reported. We present a mother and son with la...
Background. Previous reports describe ethnicity based differences in clinical and laboratory feature...
Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4), a critical negative regulator of th...